Sdbiosensor

1 known investors

SD Biosensor develops in-vitro diagnostic products, including rapid antigen tests, fluorescence immunoassay (FIA) and ELISA systems, point-of-care molecular diagnostics (MDx), CLIA-based analyzers, and blood glucose meters, for laboratories and clinical settings. Its product lines cover infectious disease testing such as COVID-19 and tuberculosis as well as biomarker and glucose monitoring.